Jazz Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: Xyrem, Xywav, Sunosi, Erwinaze, Vyxeos, Defitelio, and Zepzelca. 

CEO
Bruce C. Cozadd
CEOBruce C. Cozadd
Employees
3,200
Employees3,200
Headquarters
Dublin, Dublin
HeadquartersDublin, Dublin
Founded
2003
Founded2003
Employees
3,200
Employees3,200

JAZZ Key Statistics

Market cap
8.00B
Market cap8.00B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
750.07K
Average volume750.07K
High today
$129.81
High today$129.81
Low today
$125.38
Low today$125.38
Open price
$128.84
Open price$128.84
Volume
641.24K
Volume641.24K
52 Week high
$169.98
52 Week high$169.98
52 Week low
$117.64
52 Week low$117.64

JAZZ News

Simply Wall St 5d
Jazz Pharmaceuticals plc's stock dropped 3.1% this week, offering solace to those who sold earlier in the year - Simply Wall St

Even though Jazz Pharmaceuticals plc ( ) has fallen by 3.1% over the past week , insiders who sold US$2.9m worth of stock over the past year have had less luck....

Jazz Pharmaceuticals plc's stock dropped 3.1% this week, offering solace to those who sold earlier in the year - Simply Wall St

Analyst ratings

89%

of 18 ratings
Buy
88.9%
Hold
11.1%
Sell
0%

JAZZ Earnings

$0.00
$1.43
$2.87
$4.30
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 8, After Hours
ActualExpected Nov 8, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.